The inhibitory GAP for Ral is also implicated as a tumor suppressor, suggesting that Ral can drive tumorigenesis in the absence of activating mutations in Ras(Beel et al., 2020; Oeckinghaus et al., 2014; Yoshimachi et al., 2021). Here, RALA is linked to neoplasm.